Trial Profile
Biosimilar filgrastim (Zarzio) treatment patterns and relative dose intensity maintenance in patients receiving chemotherapy for the treatment of solid tumour or lymphoid malignancies
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2019
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Neutropenia
- Focus Therapeutic Use
- Acronyms ZOHe
- 02 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
- 02 Jun 2015 Patients were recruited between June 2013 and April 2014, according results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.